NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugs - PubMed (original) (raw)
Review
NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugs
John G Gums. Int J Antimicrob Agents. 2003 Oct.
Abstract
The spread of resistance to many antimicrobial agents in various microbial species has been highlighted by the World Health Organisation and many government agencies around the world. The reasons for this increase and spread are complex and are discussed. A number of surveillance studies has monitored the increase in resistance among isolates of Streptococcus pneumoniae to various important classes of antimicrobials. These results are discussed with particular reference to penicillins, macrolides and fluoroquinolones. Although there is evidence that in vitro resistance to macrolides and more recently to fluoroquinolones may be associated with a reduced clinical efficacy, there is no such clear association with resistance to beta-lactams and lack of clinical efficacy in non-meningeal infections. Resistance or susceptibility to an antimicrobial agent is based on breakpoints and these are set in the US by the National Committee of Clinical and Laboratory Standards. In response to these recent clinical studies showing that non-meningeal pneumococcal infections with strains classified as resistant in vitro still responded well to treatment with various beta-lactams, new breakpoints have been set. Results are presented showing that using these breakpoints, the levels of resistance to the third generation cephalosporins, ceftriaxone and cefotaxime against a range of non-meningeal pneumococcal isolates were lower than those obtained using the previous breakpoints. The excellent pharmacokinetic and pharmacodynamic properties of these agents are believed to contribute to their good activity in the clinic.
Similar articles
- The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones.
Pallares R, Fenoll A, Liñares J; Spanish Pneumococcal Infection Study Network. Pallares R, et al. Int J Antimicrob Agents. 2003 Oct;22 Suppl 1:S15-24; discussion S25-6. doi: 10.1016/j.ijantimicag.2003.08.004. Int J Antimicrob Agents. 2003. PMID: 14512221 Review. - The era of antimicrobial resistance-implications for the clinical laboratory.
Low DE. Low DE. Clin Microbiol Infect. 2002;8 Suppl 3:9-20; discussion 33-5. doi: 10.1046/j.1469-0691.8.s.3.2.x. Clin Microbiol Infect. 2002. PMID: 12519345 Review. - Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18.
Su LH, Wu TL, Kuo AJ, Chia JH, Chiu CH. Su LH, et al. J Antimicrob Chemother. 2009 Aug;64(2):336-42. doi: 10.1093/jac/dkp209. Epub 2009 Jun 11. J Antimicrob Chemother. 2009. PMID: 19520718 - The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN; Alexander Project Group. Jacobs MR, et al. J Antimicrob Chemother. 2003 Aug;52(2):229-46. doi: 10.1093/jac/dkg321. Epub 2003 Jul 15. J Antimicrob Chemother. 2003. PMID: 12865398
Cited by
- Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN. Khan IA, et al. Antimicrob Agents Chemother. 2006 Feb;50(2):810-2. doi: 10.1128/AAC.50.2.810-812.2006. Antimicrob Agents Chemother. 2006. PMID: 16436753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical